Name: Multiple Sclerosis: Diagnosis and Treatment II (en Inglés)
SKU: 57734272
Price: 57.21 USD
Availability: InStock
Author: M. Rivera, V´ıctor

portada Multiple Sclerosis: Diagnosis and Treatment II (en Inglés)

Multiple Sclerosis: Diagnosis and Treatment II (en Inglés)

Formato

Libro Físico

Editorial

Mdpi AG

Autor

M. Rivera, V´ıctor

Idioma

Inglés

N° páginas

160

Encuadernación

Tapa Dura

Dimensiones

24.4x17x1.4 cm

Peso

0.55 kg.

ISBN13

9783036529165

Categorías

Medicina: cuestiones generales

Multiple Sclerosis: Diagnosis and Treatment II (en Inglés)

M. Rivera, V´ıCtor (Autor) · Mdpi AG · Tapa Dura

Libro Nuevo Importado

Envío: 20 a 27 días háb.

$ 114.41$ 57.21

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan más de 100 unidades

$ 57.21

Llega entre el 21 Sep y el 02 Oct a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Multiple Sclerosis: Diagnosis and Treatment II (en Inglés)"

The book "Multiple Sclerosis: Diagnosis and Treatment" provides a collection of selected articles published in Biomedicines as part of Volume II addressing current issues on this major inflammatory demyelinating neurological disorder. The articles describe recent advances and discoveries in the molecular and cell microenvironment contributing to neuro-inflammation in the brain and spinal cord. The role of the neurofilaments light chain as a serological biomarker of axonal and neuronal degeneration of the CNS is presented not just as a sensitive diagnostic tool, but also as an indicator of treatment responses. The new generation of therapeutic molecules belonging to the sphingosine-1-phosphate class are discussed, and their potential as disease-modifying treatment is considered. Investigations into the intimate molecular mechanisms of highly active MS, disclosed clinically and by MRI, are discussed by researchers proposing that the expression of RNAs in peripheral blood cells is a biomarker of highly active disease. The book also addresses important clinical and epidemiological aspects of pediatric MS and that in multi-ethnic cohorts.